{"entity":{"id":"ohno-shinji","kind":"person","name":"Shinji Ohno","aka":[],"tldr":"A senior breast cancer specialist who has led Japanese arms of adjuvant and metastatic breast cancer trials for two decades.","summary":"Shinji Ohno is Director of the Breast Oncology Center at the Cancer Institute Hospital of JFCR in Tokyo. A senior breast cancer specialist, he has led Japanese arms of adjuvant and metastatic breast cancer trials for two decades, serving as an investigator on CDK4/6, HER2 and adjuvant endocrine trials with Japanese cohorts. His publications include the ESMO Clinical Practice Guidelines for early and primary breast cancer and a machine learning study predicting disease-free survival and brain metastasis in HER2-positive patients treated with neoadjuvant chemotherapy plus trastuzumab. His interests are breast cancer, adjuvant therapy and clinical trials.","asOf":"2026-09-08","links":[{"label":"Cancer Institute Hospital of JFCR","url":"https://www.jfcr.or.jp/english/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ohno%20S%5BAuthor%5D%20breast%20cancer%20Cancer%20Institute%20Hospital"}],"tags":[],"related":[],"cancers":["breast-hr-positive","breast-her2-positive"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["jfcr"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["breast-cancer-research-and-treatment"],"dependsOn":[],"notes":[],"role":"Director, Breast Oncology Center, Cancer Institute Hospital of JFCR","institutionId":"jfcr","specialisms":["Breast cancer","Adjuvant therapy","Clinical trials"],"profiles":[{"label":"Cancer Institute Hospital of JFCR","url":"https://www.jfcr.or.jp/english/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ohno%20S%5BAuthor%5D%20breast%20cancer%20Cancer%20Institute%20Hospital"}],"papers":[{"title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","journal":"Annals of Oncology","year":2019,"doi":"10.1093/annonc/mdz173"},{"title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","journal":"Annals of Oncology","year":2015,"doi":"10.1093/annonc/mdv298"},{"title":"Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm","journal":"Breast Cancer Research and Treatment","year":2018,"doi":"10.1007/s10549-018-4958-9"}]},"route":"/people/ohno-shinji/","neighbours":{"cancer":[{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"institution":[{"id":"jfcr","kind":"institution","name":"Cancer Institute Hospital of JFCR","route":"/institutions/jfcr/"}],"journal":[{"id":"breast-cancer-research-and-treatment","kind":"journal","name":"Breast cancer research and treatment","route":"/journals/breast-cancer-research-and-treatment/"}]}}